In re Otsuka America Pharmaceutical, Inc.

Ex Parte Appeal 86463775 · Filed Feb 6, 2019 · Last docket entry Jun 20, 2019 · TTABVUE

Terminated
Ex Parte Appeal
Sign in to see Otsuka America Pharmaceutical, Inc.’s full record as plaintiff — how many cases they have brought, how often the other side contests, and how many reach a decision on the merits.

Proceeding Details

Proceeding Number

Filing Date

Feb 6, 2019

Last Status Update

Jun 20, 2019

Interlocutory Attorney

Not Assigned

Parties

Plaintiff

ASSURE PROGRAM
Otsuka America Pharmaceutical, Inc.

FINNEGAN HENDERSON FARABOW ET AL

901 NEW YORK AVE NW

WASHINGTON, DC 20001-4432

Attorney / Correspondent:

B BRETT HEAVNERFINNEGAN HENDERSON FARABOW ET AL

901 NEW YORK AVE NW

WASHINGTON, DC 20001-4432

Mark:

ASSURE PROGRAM
Cancelled
S/N: 86463775
VS

Defendant

Unknown

TTAB Documents

Title
Date
Entry #
Category
Code
Actions
TERMINATED
Jun 20, 2019
10
Status
999
BD DECISION: DISMISSED AS MOOT
Jun 19, 2019
9
Decisions
826
JURISDICTION RESTORED/REMANDED TO EXAMINER
May 17, 2019
8
Appeals
180
APPLICANT REQ FOR REMAND
May 9, 2019
7
Appeals
166
PROCEEDINGS RESUMED
Feb 28, 2019
6
Status
179
RECON DENIED
Feb 27, 2019
5
Decisions
424
REQ FOR RECON
Feb 7, 2019
4
Motions
185
INSTITUTED
Feb 6, 2019
3
Status
128
APPEAL ACKNOWLEDGED; CASE REMANDED
Feb 6, 2019
2
Appeals
155
APPEAL TO BOARD
Feb 6, 2019
1
Appeals
158
10 filings. Scroll the list for more.